Freedman Financial Associates’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CLX
Freedman Financial Associates's CLX Position: Q2 2022 in Review
Freedman Financial Associates sold out of Clorox (CLX) in Q2 2022, closing a stake of 50 shares — an estimated $7K sold.
Freedman Financial Associates first reported a position in CLX in Q4 2020 and held it in 6 quarters. The position peaked at $10K in Q1 2021. 1,081 funds tracked by Wall St. Rank hold CLX as of Q2 2022.
- Freedman Financial Associates reported no remaining Clorox position as of Q2 2022 after selling out during the quarter.
- Freedman Financial Associates sold 50 Clorox shares in Q2 2022, an estimated $7K.
- Freedman Financial Associates first reported a position in Clorox in Q4 2020 and held it in 6 quarters.
- Freedman Financial Associates's Clorox position peaked at $10K in Q1 2021.
- 1,081 funds tracked by Wall St. Rank held Clorox as of Q2 2022.
Based on Freedman Financial Associates's 13F filing for Q2 2022.